The Contact-CTI Study: Use of Tissue Contact Data to Guide Atrial Flutter Ablation
The Contact-CTI Study - Does Assessment of Tissue Contact During Ablation of Atrial Flutter Improve Outcomes?
2 other identifiers
interventional
101
1 country
1
Brief Summary
This study will be a single blind prospective randomised control trial in patients undergoing ablation for the treatment of typical atrial flutter, with the aim of investigating the benefit of a new impedance-based computer software application which measures tissue contact between the ablation catheter and the inside of the heart. The investigators hope to demonstrate that the use of this tissue contact information reduces ablation time, Xray time, and procedure time required to complete the procedure successfully. Study participants will be randomly assigned to undergo their procedure with or without this contact data displayed for the doctor performing the ablation to see. The acute procedural endpoint of ablation is successful conduction block across the cavotricuspid isthmus of the right atrium. If the outcome of this study is positive, it will have a significant beneficial impact on this procedure, reducing procedure length, patient discomfort, and potentially reducing risk for the patient, recurrent arrythmia symptoms, and the need for repeat procedures later on.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Jan 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
May 9, 2012
CompletedFirst Posted
Study publicly available on registry
May 11, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2013
CompletedOctober 13, 2017
May 1, 2012
1.2 years
May 9, 2012
October 11, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome measure is the mean ablation time required to achieve the acute procedural endpoint of cavotricuspid isthmus conduction block
immediate (intra-procedural)
Study Arms (2)
ECI CONTACT-ACTIVE
ACTIVE COMPARATORIrrigated Radiofrequency ablation performed using the ECI contact data
ECI CONTACT-INACTIVE
PLACEBO COMPARATORirrigated RF ablation performed to the right atrium without the use of ECI contact data
Interventions
irrigated radiofrequency ablation to the right atrium using the ECI contact data
irrigated RF ablation without the use of ECI contact data
Eligibility Criteria
You may qualify if:
- Patient is undergoing de novo cavotricuspid isthmus ablation.
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 18 years or over
You may not qualify if:
- (1) Previous percutaneous or open surgical procedure involving the right atrium
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
John Radcliffe Hospital
Headington, Oxfordshire, OX39DU, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Timothy Betts, MbChB, MD
Oxford University Hospitals NHS Trust
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 9, 2012
First Posted
May 11, 2012
Study Start
January 1, 2012
Primary Completion
April 1, 2013
Study Completion
April 1, 2013
Last Updated
October 13, 2017
Record last verified: 2012-05